Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
Maximillion69.... Eva sold out on Manic Monday and made a good profit.... but she then regretted it and bought back in much later at the 190-220 range, then sold everything she had left today at 101.
She posted it on the imm board this evening.
Food for thought.... it's the pi's selling, and the big boys hoovering up at a bargain price.
I read on the Imm board that Eva has completely sold out, last thing today... they'll be many other's like her.
You have to ask yourself, who is better informed.... flaky private investors or Polar who now own 1% of the company? My money is on Polar, who, you can bet your life on, have been reassured by Richard.
When the flaky investors have finished selling this will move up...
Nothing has changed, the 100,000 treatments a month will still be sold, and governments will still stockpile. Providing Phase 3 trials show even half as good results to Phase 2, SNG is in a league of it's own, and will be a household name by 2022.
Managed to scramble together another 5k to buy at 103. Great buying opportunity after such a sensational tabloid headline.... followed by a complete over reaction on the SP.... but that will be corrected in the next few days.
Phase 3 trials are almost certainly going to be successful, they are still making 100,000 treatments, all of which will be snapped up, and Governments all over the world will stockpile SNG-001 for future virus's.... that's a given.
Just trying to work out how I am going to buy more at these prices.
Pete7.... Numis's Marketing Report was directed at long term investors.... Everyone on here should know that Numis are not impartial, but also would not sell their clients a donkey either, because they'd lose their clients.
I don't think anyone thinks it'll be £10- £85 next week or next year. Besides most PI's will prob be out when it hits £3. Numis are basically saying is it's a good risk/return. But there is still risk.
GreggsStottie..... the Numis report is about 40 pages long, and it is a Marketing Communication for their own clients. It is also nearly a month old now, being published on 12th October, and probably written a while before that, and when there where 149m shares in issue.
But the front page states a target price of 990p, it later goes on to say their Bull case extends to £50/ish based on the valuations of Modern/BioNTech with a need for SNG001 whether or not the vaccines prove successful.
These figures are based on the success of Phase 3, which in their view has a 70% chance of success, although it has been pointed out on here by another post, that, 'in his professional opinion' two of the main reasons that Phase 3's fail are:- Underfunding and/or drug safety issues.... neither of which are relevant to Synairgen as since then they are now full funded. Interferon Beta has also proven safe for decades when treating (successfully) a certain type of MS. Therefore, based on these two factors he advised that this should state between a 85%-95% chance of success... 'in his expert opinion, being involved in this field'.
Later on in the report, based on certain assumptions, Numis increased the a price target of £10 - £85 a share.
JediJD..... I would bet against it going much below 175 again.... it was heavily over subscribed at 175, so a lot of much better informed and cleverer people than me clearly think so too.... but I wouldn't put a stop loss in anywhere near it, if that's the reason for asking?
I think RM has always has his mind focused on the future of governments stock piling SNG001, once phase 3 trials have proved successful.
Is it possible, now that the deal with Clinigen is in place, and we are trialing in 20 countries, that the stockpiling deals can be achieved without a big pharma involved? That would mean Synairgen would be able to keep the lions share of the profit instead of just 10-20% in royalties.
After that, the new partner/pharma can take SNG forward in other areas such as COPD/Asthma... and probably a dozen other uses.
RM has achieved so much, and come so far, seems unfair to expect him to hand over billions of pounds worth of stockpiling deals to a Pharma at this late stage.
Thoughts??
David1951... quite right to get some personal advice from a tax expert. I actually know a lot about IHT as I used to run seminars on it, but I still defer to a tax expert personally.... it's one tax that is 'optional'... investing in AIM shares for example can be IHT free, and of course, giving it away.... but laws change constantly to close loop holes..... and that can be expensive... you need to get it right, and right for your personal circumstances.
btw... H&L give good free advice basic advice on tax and how best to mitigate it on their site, not sure if you have to be a client. They're not the cheapest platform but they have saved me money more than once and give an excellent service.
Had been watching DDDD for a while, after getting a recommendation on the SNG board.... and really liked everything I read, but I didn't have the spare cash, and then it went too high... couldn't believe my luck when it dipped under 100, and then I luckily had the cash, so piled in, have topped up again at 105, and 110....
Although my biggest holding is still SNG, this is now my second... feels great to be in it finally.
The broker note is confidential to Numis clients.... so I think the link/photo of the front page that someone posted here was removed .. presumably by LSE.
12th October. Current Share price £171p. Target price 990p, however, their bull cased extends to £50/sh based on valuations of Moderna/BioNTech with a need for SNG001 whether or not the vaccines prove successful.
184 finish today.... hoping for 194 tomorrow.....
Found myself in a (non political) meeting today with two MP's .... at the end, over coffee, I decided to tell them about Synairgen's interferon beta inhaler, and how exciting it was.... and right on cue the woman on my left piped up very excitedly, saying that she'd much prefer to take that rather than a vaccine.... and that it sounded exactly like the answer everyone was looking for.... made me smile... couldn't have planned it any better!
Woodstock.... I agree, but there are some investors whom I respect who really rate TILS.... which I haven't been able to work out.
Listening to their CEO compared to Richard Marsden.... just poles apart.